Report Detail

Request for Sample of this report

Pharma & Healthcare Global Interferon Alpha-2a Biosimilar Market Research Report 2019

  • RnM2922255
    • |
  • 11 February, 2019
    • |
  • Global
    • |
  • 97 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.

Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%.

Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017.

South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%.

Market competition is not intense. Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Interferon Alpha-2a Biosimilar market is valued at 390 million US$ in 2018 is expected to reach 150 million US$ by the end of 2025, growing at a CAGR of -11.0% during 2019-2025.
This report focuses on Interferon Alpha-2a Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Interferon Alpha-2a Biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Long-lasting Type
Ordinary Type

Segment by Application
Hepatitis C
Hepatitis B
Other


Table of Contents

    Executive Summary

      1 Interferon Alpha-2a Biosimilar Market Overview

      • 1.1 Product Overview and Scope of Interferon Alpha-2a Biosimilar
      • 1.2 Interferon Alpha-2a Biosimilar Segment by Type
        • 1.2.1 Global Interferon Alpha-2a Biosimilar Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Long-lasting Type
        • 1.2.3 Ordinary Type
      • 1.3 Interferon Alpha-2a Biosimilar Segment by Application
        • 1.3.1 Interferon Alpha-2a Biosimilar Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hepatitis C
        • 1.3.3 Hepatitis B
        • 1.3.4 Other
      • 1.3 Global Interferon Alpha-2a Biosimilar Market by Region
        • 1.3.1 Global Interferon Alpha-2a Biosimilar Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Interferon Alpha-2a Biosimilar Market Size
        • 1.4.1 Global Interferon Alpha-2a Biosimilar Revenue (2014-2025)
        • 1.4.2 Global Interferon Alpha-2a Biosimilar Production (2014-2025)

      2 Global Interferon Alpha-2a Biosimilar Market Competition by Manufacturers

      • 2.1 Global Interferon Alpha-2a Biosimilar Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Interferon Alpha-2a Biosimilar Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Interferon Alpha-2a Biosimilar Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Interferon Alpha-2a Biosimilar Production Sites, Area Served, Product Types
      • 2.5 Interferon Alpha-2a Biosimilar Market Competitive Situation and Trends
        • 2.5.1 Interferon Alpha-2a Biosimilar Market Concentration Rate
        • 2.5.2 Interferon Alpha-2a Biosimilar Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Interferon Alpha-2a Biosimilar Production Market Share by Regions

      • 3.1 Global Interferon Alpha-2a Biosimilar Production Market Share by Regions
      • 3.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Interferon Alpha-2a Biosimilar Production
        • 3.4.1 North America Interferon Alpha-2a Biosimilar Production Growth Rate (2014-2019)
        • 3.4.2 North America Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Interferon Alpha-2a Biosimilar Production
        • 3.5.1 Europe Interferon Alpha-2a Biosimilar Production Growth Rate (2014-2019)
        • 3.5.2 Europe Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Interferon Alpha-2a Biosimilar Production (2014-2019)
        • 3.6.1 China Interferon Alpha-2a Biosimilar Production Growth Rate (2014-2019)
        • 3.6.2 China Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Interferon Alpha-2a Biosimilar Production (2014-2019)
        • 3.7.1 Japan Interferon Alpha-2a Biosimilar Production Growth Rate (2014-2019)
        • 3.7.2 Japan Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Interferon Alpha-2a Biosimilar Consumption by Regions

      • 4.1 Global Interferon Alpha-2a Biosimilar Consumption by Regions
      • 4.2 North America Interferon Alpha-2a Biosimilar Consumption (2014-2019)
      • 4.3 Europe Interferon Alpha-2a Biosimilar Consumption (2014-2019)
      • 4.4 China Interferon Alpha-2a Biosimilar Consumption (2014-2019)
      • 4.5 Japan Interferon Alpha-2a Biosimilar Consumption (2014-2019)

      5 Global Interferon Alpha-2a Biosimilar Production, Revenue, Price Trend by Type

      • 5.1 Global Interferon Alpha-2a Biosimilar Production Market Share by Type (2014-2019)
      • 5.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Type (2014-2019)
      • 5.3 Global Interferon Alpha-2a Biosimilar Price by Type (2014-2019)
      • 5.4 Global Interferon Alpha-2a Biosimilar Production Growth by Type (2014-2019)

      6 Global Interferon Alpha-2a Biosimilar Market Analysis by Applications

      • 6.1 Global Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2014-2019)
      • 6.2 Global Interferon Alpha-2a Biosimilar Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Interferon Alpha-2a Biosimilar Business

      • 7.1 Roche
        • 7.1.1 Roche Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.1.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.1.3 Roche Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Biosidus
        • 7.2.1 Biosidus Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.2.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.2.3 Biosidus Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Zydus Cadila
        • 7.3.1 Zydus Cadila Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.3.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.3.3 Zydus Cadila Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Nanogen
        • 7.4.1 Nanogen Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.4.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.4.3 Nanogen Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Amega Biotech
        • 7.5.1 Amega Biotech Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.5.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.5.3 Amega Biotech Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Rhein Minapharm Biogenetics
        • 7.6.1 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.6.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 PROBIOMED
        • 7.7.1 PROBIOMED Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.7.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.7.3 PROBIOMED Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 3sbio
        • 7.8.1 3sbio Interferon Alpha-2a Biosimilar Production Sites and Area Served
        • 7.8.2 Interferon Alpha-2a Biosimilar Product Introduction, Application and Specification
        • 7.8.3 3sbio Interferon Alpha-2a Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served

      8 Interferon Alpha-2a Biosimilar Manufacturing Cost Analysis

      • 8.1 Interferon Alpha-2a Biosimilar Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Interferon Alpha-2a Biosimilar
      • 8.4 Interferon Alpha-2a Biosimilar Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Interferon Alpha-2a Biosimilar Distributors List
      • 9.3 Interferon Alpha-2a Biosimilar Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Interferon Alpha-2a Biosimilar Market Forecast

      • 11.1 Global Interferon Alpha-2a Biosimilar Production, Revenue Forecast
        • 11.1.1 Global Interferon Alpha-2a Biosimilar Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Interferon Alpha-2a Biosimilar Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Interferon Alpha-2a Biosimilar Price and Trend Forecast (2019-2025)
      • 11.2 Global Interferon Alpha-2a Biosimilar Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Interferon Alpha-2a Biosimilar Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Interferon Alpha-2a Biosimilar Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Interferon Alpha-2a Biosimilar Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Interferon Alpha-2a Biosimilar Production, Revenue Forecast (2019-2025)
      • 11.3 Global Interferon Alpha-2a Biosimilar Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Interferon Alpha-2a Biosimilar Consumption Forecast (2019-2025)
        • 11.3.2 Europe Interferon Alpha-2a Biosimilar Consumption Forecast (2019-2025)
        • 11.3.3 China Interferon Alpha-2a Biosimilar Consumption Forecast (2019-2025)
        • 11.3.4 Japan Interferon Alpha-2a Biosimilar Consumption Forecast (2019-2025)
      • 11.4 Global Interferon Alpha-2a Biosimilar Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Interferon Alpha-2a Biosimilar Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Interferon Alpha-2a Biosimilar . Industry analysis & Market Report on Interferon Alpha-2a Biosimilar is a syndicated market report, published as Global Interferon Alpha-2a Biosimilar Market Research Report 2019. It is complete Research Study and Industry Analysis of Interferon Alpha-2a Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        		$2,900.00
        		$4,350.00
        		$5,800.00
        		2,322.90
        		3,484.35
        		4,645.80
        		2,708.60
        		4,062.90
        		5,417.20
        		456,721.00
        		685,081.50
        		913,442.00
        		241,831.00
        		362,746.50
        		483,662.00
        Credit card Logo
        Sample Question Discount Download PDF

        Related Reports

        Reason to Buy

        • Trusted By Leaders

          Top executives from leading companies purchase research reports from us. 

        • Shop With Confidence

          We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

        • Customer Centric

          Need assistance related to your research requirements? We are just a phone call or an email away.

        • Personalized Solutions

          Our experienced research specialists are here to help you locate the right reports for your need.

        • Secure Checkout

          Shop without being worried about safety & security of your transactions.
          •

        Request for Sample of this report

        Reports and Markets

        mcafree

        Contact Us

        +1-352-353-0818 (US)

        info@reportsandmarkets.com

        Support

        EMAIL US

        Newsletter

        KEEP UP TO DATE ON ALL THE LATEST REPORTS


        maxmind_logo